InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,246.44
(
-0.09%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Lewisinhk

Send PM Follow Ignore
Followers 12
Posts 172
Boards Moderated 0
Alias Born 11/08/2012

Lewisinhk

Re: Kbro13 post# 152552

Thursday, 09/10/2015 8:55:34 PM

Thursday, September 10, 2015 8:55:34 PM

Post# of 158400
Alan Leong, Biowatch news founder, a professional biotech analyst....stated in a 2015 online article: Wall Street typically gives biotechs a $250 million valuation for an FDA approved PH I IND. RGBP/BMSN has two about to reach this milestone. We could start to see a climb to a $500 million valuation, perhaps more as hema/dcell are immunotherapy based, this sector since 2014 has seen strong demand, BMSN .03-.05, may take a couple high volume days at first before moving north
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up